Ian Poulton

15.3k citations

32 papers · 1.3k indexed · h-index 20

Infectious Diseases top 2%
Immunology top 5%
Public Health, Environmental and Occupational Health top 5%
Epidemiology top 10%
Molecular Biology

Co-authors: Adrian V. S. Hill Helen McShane Angela M. Minassian Sarah C. Gilbert Susanna Dunachie Laura Andrews Tamara Berthoud Iman Satti
Topics: Tuberculosis Research and Epidemiology (9 papers)Immunodeficiency and Autoimmune Disorders (8 papers)Mosquito-borne diseases and control (8 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Proceedings of the National Academy of Sciences PLoS ONE American Journal of Respiratory and Critical Care Medicine
Partner nations: United Kingdom United States Gambia

In The Last Decade

Ian Poulton

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Ian Poulton

Since Specialization

Citations

This map shows the geographic impact of Ian Poulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Poulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Poulton more than expected).

Fields of papers citing papers by Ian Poulton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Poulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Poulton. The network helps show where Ian Poulton may publish in the future.

Co-authorship network of co-authors of Ian Poulton

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Poulton. A scholar is included among the top collaborators of Ian Poulton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Poulton. Ian Poulton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial 2025 ·The Lancet Microbe ·Daniel Jenkin,Rebecca Makinson,Helen Sanders,(unknown),Abigail Platt,Nguyen Tran,Tanya Dinesh,(unknown),Alison M. Lawrie,(unknown),Ian Poulton,Eleanor Berrie,Paola Cicconi,Teresa Lambe	1
2	Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial 2022 ·The Lancet Microbe ·Daniel Jenkin,Adam Ritchie,Jeremy Aboagye,Sofiya Fedosyuk,(unknown),(unknown),Helen Sanders,Duncan Bellamy,Rebecca Makinson,Zhi Quan Xiang,Emma Bolam,Richard Tarrant,Fernando Ramos Lopez,Abigail Platt,Ian Poulton,Catherine Green,Hildegund C.J. Ertl,Katie Ewer,Alexander D. Douglas	15
3	Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies 2021 ·Vaccines ·Pedro M. Folegatti,Amy Flaxman,Daniel Jenkin,Rebecca Makinson,(unknown),Duncan Bellamy,Fernando Ramos Lopez,Jonathan Sheridan,Ian Poulton,Jeremy Aboagye,Nguyen Tran,Celia Mitton,Rachel Roberts,Alison M. Lawrie,Adrian V. S. Hill,Katie Ewer,Sarah C. Gilbert	4
4	682P Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer 2020 ·Annals of Oncology ·Mark Tuthill,Federica Cappuccini,(unknown),Emily Pollock,Ian Poulton,Clare Verrill,Tom Evans,Silke Gillessen,Gerhardt Attard,Andrew Protheroe,Freddie C. Hamdy,Adrian V. S. Hill,Irina Redchenko	4
5	Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP 2018 ·Scientific Reports ·Carly M. Bliss,Georgina Bowyer,Nicholas Anagnostou,Tom Havelock,(unknown),Huw Davies,Simone C. de Cassan,(unknown),Alison M. Lawrie,Navin Venkatraman,Ian Poulton,Rachel Roberts,(unknown),Prateek Choudhary,Saul N. Faust,Stefano Colloca,Sarah C. Gilbert,Alfredo Nicosia,Adrian V. S. Hill,Katie Ewer	29
6	PROBABILITY OF TRANSMISSION OF MALARIA FROM MOSQUITO TO HUMAN IS REGULATED BY PARASITE DENSITY IN NAIVE AND VACCINATED HOSTS 2017 ·American Journal of Tropical Medicine and Hygiene ·Thomas S. Churcher,(unknown),Nick J. Edwards,Ian Poulton,Tommy Rampling,Patrick M. Brock,Jamie T. Griffin,Leanna M. Upton,Sara E. Zakutansky,Katarzyna Sala,Fiona Angrisano,AV Hill,Andrew M. Blagborough	1
7	Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts 2017 ·PLoS Pathogens ·Thomas S. Churcher,Robert E. Sinden,Nick J. Edwards,Ian Poulton,Tommy Rampling,Patrick M. Brock,Jamie T. Griffin,Leanna M. Upton,Sara E. Zakutansky,Katarzyna Sala,Fiona Angrisano,Adrian V. S. Hill,Andrew M. Blagborough	79
8	Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™ 2017 ·Vaccine ·Navin Venkatraman,Nicholas Anagnostou,Carly M. Bliss,Georgina Bowyer,Daniel Wright,Karin Lövgren‐Bengtsson,Rachel Roberts,Ian Poulton,Alison M. Lawrie,Katie Ewer,Adrian V. S. Hill	29
9	Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe 2013 ·PLoS ONE ·Susanne H. Sheehy,Alexandra J. Spencer,Alexander D. Douglas,B. Kim Lee Sim,Rhea J. Longley,Nick J. Edwards,Ian Poulton,Domtila Kimani,Andrew R. Williams,Nicholas Anagnostou,Rachel Roberts,Simon Kerridge,Merryn Voysey,Eric R. James,Peter F. Billingsley,Anusha Gunasekera,Alison M. Lawrie,Stephen L. Hoffman,Adrian V. S. Hill	54
10	Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination 2013 ·The Journal of Infectious Diseases ·(unknown),Joel N. Meyer,Iman Satti,Leanne Marsay,Ian Poulton,(unknown),Angela M. Minassian,Helen A. Fletcher,Helen McShane	59
11	Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults 2012 ·Human Vaccines & Immunotherapeutics ·Rosalind Rowland,Ansar A. Pathan,Iman Satti,Ian Poulton,Magali Matsumiya,(unknown),Angela M. Minassian,Geraldine O’Hara,Matthew M. Hamill,J. T. Scott,Stephanie A. Harris,Hazel Poyntz,(unknown),Joel N. Meyer,Nicola Williams,Sarah C. Gilbert,Alison M. Lawrie,Adrian V. S. Hill,Helen McShane	21
12	Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery 2012 ·Vaccine ·Joel N. Meyer,Stephanie A. Harris,Iman Satti,Ian Poulton,Hazel Poyntz,Rachel Tanner,Rosalind Rowland,Kristin Griffiths,Helen A. Fletcher,Helen McShane	51
13	Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults 2012 ·Vaccine ·Ansar A. Pathan,Angela M. Minassian,Clare R. Sander,Rosalind Rowland,David W. Porter,Ian Poulton,Adrian V. S. Hill,Helen A. Fletcher,Helen McShane	39
14	A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine 2011 ·Vaccine ·David W. Porter,Fiona M. Thompson,Tamara Berthoud,Claire Hutchings,Laura Andrews,Sumi Biswas,Ian Poulton,Eric Prieur,Simon Correa,Rosalind Rowland,Trudie Lang,Jackie Williams,Sarah C. Gilbert,Robert E. Sinden,Stephen Todryk,Adrian V. S. Hill	39
15	Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis –infected Individuals 2009 ·American Journal of Respiratory and Critical Care Medicine ·Clare R. Sander,Ansar A. Pathan,Natalie E. R. Beveridge,Ian Poulton,Angela M. Minassian,Nicola Alder,(unknown),Adrian V. S. Hill,Fergus Gleeson,Robert J.O. Davies,Geoffrey Pasvol,Helen McShane	94
16	Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A 2009 ·PLoS ONE ·(unknown),Ansar A. Pathan,Clare R. Sander,Helen A. Fletcher,Ian Poulton,Nicola Alder,Adrian V. S. Hill,Helen McShane	52
17	Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial 2008 ·PLoS ONE ·Fiona M. Thompson,David W. Porter,Shinji L. Okitsu,Nicole Westerfeld,Denise Vogel,Stephen Todryk,Ian Poulton,Simon Correa,Claire Hutchings,Tamara Berthoud,Susanna Dunachie,Laura Andrews,Jack Williams,Robert E. Sinden,Sarah C. Gilbert,Gerd Pluschke,Rinaldo Zurbriggen,Adrian V. S. Hill	83
18	Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials 2007 ·PLoS ONE ·Ansar A. Pathan,Clare R. Sander,Helen A. Fletcher,Ian Poulton,Nicola Alder,Natalie E. R. Beveridge,(unknown),Adrian V. S. Hill,Helen McShane	54
19	A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS 2006 ·Vaccine ·Susanna Dunachie,Michael Walther,Jenni M. Vuola,Daniel P. Webster,Sheila M. Keating,Tamara Berthoud,Laura Andrews,Philip Bejon,Ian Poulton,Geoffrey A. Butcher	77
20	Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers 2006 ·Vaccine ·(unknown),Susanna Dunachie,Samuel McConkey,Ian Poulton,Anne Moore,Michael Walther,Stephen M. Laidlaw,Tim Peto,Michael A. Skinner,Sarah C. Gilbert	54

About Ian Poulton

Ian Poulton is a scholar working on Virology, Infectious Diseases and Parasitology, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Immunodeficiency and Autoimmune Disorders (8 papers) and Mosquito-borne diseases and control (8 papers). The work is most often cited by research in Virology (193 citations), Infectious Diseases (569 citations) and Immunology (552 citations). Ian Poulton has collaborated with scholars based in United Kingdom, United States and Gambia. Frequent co-authors include Adrian V. S. Hill, Helen McShane, Angela M. Minassian, Sarah C. Gilbert, Susanna Dunachie, Laura Andrews, Tamara Berthoud, Iman Satti, Robert E. Sinden and Helen A. Fletcher. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact